UNIT-II Aminoglycosideantibiotics

Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/321938027

MEDICINAL CHEMISTRY (Aminoglycoside Antibiotics)

Presentation · December 2017


DOI: 10.13140/RG.2.2.19507.32801

CITATIONS READS

0 2,414

1 author:

Dr Sumanta Mondal
GITAM (Deemed to be University)
191 PUBLICATIONS   266 CITATIONS   

SEE PROFILE

Some of the authors of this publication are also working on these related projects:

Natural Products View project

Pharmaceutical Chemistry View project

All content following this page was uploaded by Dr Sumanta Mondal on 20 December 2017.

The user has requested enhancement of the downloaded file.


PPH 308: MEDICINAL CHEMISTRY - II Unit: II: Aminoglycoside Antibiotics

- Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial therapeutic


agents that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar).
- The term can also refer more generally to any organic molecule that contains amino-sugar substructures.
- The aminoglycoside antibiotics contain one or more amino sugars linked to an aminocytitol ring by glycosidic
bonds.
- Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic
bacilli where resistance against Gram-positive and anaerobic Gram-negative bacteria.
- Streptomycin, the first antibiotic of this group.
- Adverse effect: The aminoglycoside can produces severe adverse effects, which include nephrotoxity,
ototoxicity, and neuro effects. These properties have limited the use of aminoglycoside chemotherapy to serious
systemic indications.
- Mode of action: The aminoglycosides exhibit bactericidal effects as a result of several phenomena. Ribosomal
binding on 30s and 50s subunits as well as the interface produces misreading; this disturbs the normal protein
synthesis. Cell membrane damage also plays an integral part in ensuring bacterial cell death.

 Examples of aminoglycoside antibiotics


Name Source
Streptomycin Streptomyces griseus
Neomycin S. fradiae
Kanamycin S. kanamyeleticus
Gentamycin Micromonospora purpura
Netilmicin Micromonospora species
Tobramycin S. tenebrarius
Framycetin S. decaris
Paromomycin S. rimosus and S. paramomycinus
Amikacin It is 1-L-(-) 4-amino-2-hydroxy butyryl kanamycin

Lecturer Notes_Dr. S. Mondal_B. Pharm 6th Semester_GITAM (Deemed to be University) Page | 1


E-mail: [email protected]
PPH 308: MEDICINAL CHEMISTRY - II Unit: II: Aminoglycoside Antibiotics

 Streptomycin: It is used in the treatment of infections caused by gram-negative bacteria of particular interest
and has a high degree of activity against P. aeruginosa, where the important causative factor is burned skin. It is
used topically in the treatment of infected bed-sores, pyodermata, burns, and in the eye infection.

 Neomycin: It is photosensitive and its main use is in the treatment of the ear, eye, and skin infections; these
include burns, wounds, ulcer, and infected dermatoses.

Lecturer Notes_Dr. S. Mondal_B. Pharm 6th Semester_GITAM (Deemed to be University) Page | 2


E-mail: [email protected]
PPH 308: MEDICINAL CHEMISTRY - II Unit: II: Aminoglycoside Antibiotics

 Kanamycin: The kanamycins do not possess D-ribose molecule. The use of kanamycins is restricted to
infections of the intestinal tract and to systemic infections.

 Tobramycin: Its activity is similar to gentamycin. The superior activity of tobramycin against P. aeruginosa
may make it useful in the treatment of bacterial oesteromyelitis, and pneumonia caused by Pseudomonas species.

Lecturer Notes_Dr. S. Mondal_B. Pharm 6th Semester_GITAM (Deemed to be University) Page | 3


E-mail: [email protected]
PPH 308: MEDICINAL CHEMISTRY - II Unit: II: Aminoglycoside Antibiotics

 SAR of Aminoglycoside Antibiotics


- The aminoglycosides consist of two or more amino sugars joined in glycoside linkage to a highly substituted 1,3-
diaminocyclo hexane (aminocyclitol), which is a centrally placed ring. The ring is a 2-deoxy streptamine in all
aminoglycosides except streptomycin and dihydrostreptomycin, where it is streptidine. Thus,
 In kanamycin and gentamycin families, two amino sugars are attached to 2-deoxy streptamine.
 In streptomycin, two amino sugars are attached to strepidine.
 In neomycin family, there are amino sugars attached to 2-deoxy streptamine.
- The aminoglycoside antibiotics contain two important structural features. They are amino sugar portion and
centrally placed hexose ring, which is either 2-deoxystreptamine or streptidine.
1. Amino sugar portion

i. The bacterial inactivating enzymes targets C-6 and C-2 position and the substitution with methyl group at C-6
increases the enzyme resistance.
ii. Cleavage of 3-hydroxyl or the 4-hydroxyl or both groups does not affect the activity.

2. Centrally placed hexose ring (aminocyclitol ring)

i. Various modifi cations at C-1 amino group have been tested. The acylation (e.g. amikacyn) and ethylation (e.g.
1-N-ethylsisomycin) though does not increase the activity helps to retain the antibacterial potency.
ii. In sisomicin series, 2-hydroxylation and 5-deoxygenation result in the increased inhibition of bacterial
inactivating enzyme systems. Thus, very few modifications of the central ring are possible, which do not violate
the activity spectrum of aminoglycosides.

Lecturer Notes_Dr. S. Mondal_B. Pharm 6th Semester_GITAM (Deemed to be University) Page | 4


E-mail: [email protected]

View publication stats

You might also like